NASDAQ:NXGL - Nasdaq - US65344E1073 - Common Stock - Currency: USD
3.32
-0.28 (-7.78%)
The current stock price of NXGL is 3.32 USD. In the past month the price decreased by -2.35%. In the past year, price increased by 41.28%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 29.9 | 45.13B | ||
COO | COOPER COS INC/THE | 23.91 | 17.66B | ||
ALGN | ALIGN TECHNOLOGY INC | 20.39 | 14.22B | ||
SOLV | SOLVENTUM CORP | 17.55 | 12.61B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 30.7 | 6.01B | ||
BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
ICUI | ICU MEDICAL INC | 27.69 | 3.85B | ||
XRAY | DENTSPLY SIRONA INC | 10.14 | 3.73B | ||
HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
NEOG | NEOGEN CORP | 25.1 | 2.18B | ||
UFPT | UFP TECHNOLOGIES INC | 36.31 | 1.95B |
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. The company also specializes in eye and eyelash consumer products.
NEXGEL INC
2150 Cabot Boulevard West, Suite B
Langhorne PENNSYLVANIA US
Employees: 19
Company Website: https://nexgel.com/
Investor Relations: https://nexgel.com/investor-relations/
Phone: 12157028550
The current stock price of NXGL is 3.32 USD. The price decreased by -7.78% in the last trading session.
The exchange symbol of NEXGEL INC is NXGL and it is listed on the Nasdaq exchange.
NXGL stock is listed on the Nasdaq exchange.
7 analysts have analysed NXGL and the average price target is 6.12 USD. This implies a price increase of 84.34% is expected in the next year compared to the current price of 3.32. Check the NEXGEL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NEXGEL INC (NXGL) has a market capitalization of 24.97M USD. This makes NXGL a Nano Cap stock.
NEXGEL INC (NXGL) currently has 19 employees.
NEXGEL INC (NXGL) has a support level at 3.31 and a resistance level at 3.53. Check the full technical report for a detailed analysis of NXGL support and resistance levels.
The Revenue of NEXGEL INC (NXGL) is expected to grow by 97.82% in the next year. Check the estimates tab for more information on the NXGL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NXGL does not pay a dividend.
NEXGEL INC (NXGL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.6).
The outstanding short interest for NEXGEL INC (NXGL) is 2.2% of its float. Check the ownership tab for more information on the NXGL short interest.
ChartMill assigns a technical rating of 5 / 10 to NXGL. When comparing the yearly performance of all stocks, NXGL is one of the better performing stocks in the market, outperforming 86.26% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to NXGL. Both the profitability and financial health of NXGL have multiple concerns.
Over the last trailing twelve months NXGL reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS decreased by -18.66% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -33.38% | ||
ROE | -75.29% | ||
Debt/Equity | 0.28 |
ChartMill assigns a Buy % Consensus number of 83% to NXGL. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -4.08% and a revenue growth 97.82% for NXGL